TRIM21 and COVID-19: Approximately 50% of MIS-C children had Ro52, Ro60, and/or La autoantibodies (Figures 2A–C), which were nearly absent in children with COVID-19 (1/59) and in children (0/8) who had recovered from COVID-19.